GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation

NASDAQ:GEHC • US36266G1076

70.1 USD
-2.55 (-3.51%)
Last: Mar 12, 2026, 01:37 PM

This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

GEHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health. GEHC scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. GEHC Profitability Analysis

1.1 Basic Checks

  • GEHC had positive earnings in the past year.
  • In the past year GEHC had a positive cash flow from operations.
  • GEHC had positive earnings in each of the past 5 years.
  • In the past 5 years GEHC always reported a positive cash flow from operatings.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of GEHC (5.65%) is better than 81.52% of its industry peers.
  • GEHC's Return On Equity of 20.09% is amongst the best of the industry. GEHC outperforms 94.57% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.81%, GEHC belongs to the best of the industry, outperforming 82.07% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 9.15%.
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROIC 7.81%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • GEHC has a Profit Margin of 10.11%. This is amongst the best in the industry. GEHC outperforms 83.15% of its industry peers.
  • GEHC's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 13.40%, GEHC belongs to the best of the industry, outperforming 80.43% of the companies in the same industry.
  • GEHC's Operating Margin has declined in the last couple of years.
  • GEHC has a Gross Margin of 39.98%. This is in the lower half of the industry: GEHC underperforms 67.39% of its industry peers.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. GEHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GEHC is destroying value.
  • GEHC has less shares outstanding than it did 1 year ago.
  • GEHC has more shares outstanding than it did 5 years ago.
  • GEHC has about the same debt/assets ratio as last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • GEHC has an Altman-Z score of 1.87. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GEHC has a Altman-Z score of 1.87. This is comparable to the rest of the industry: GEHC outperforms 57.07% of its industry peers.
  • GEHC has a debt to FCF ratio of 6.67. This is a slightly negative value and a sign of low solvency as GEHC would need 6.67 years to pay back of all of its debts.
  • GEHC has a better Debt to FCF ratio (6.67) than 75.54% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.92, GEHC is doing worse than 73.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Altman-Z 1.87
ROIC/WACC0.81
WACC9.65%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that GEHC should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.37, GEHC is doing worse than 78.26% of the companies in the same industry.
  • A Quick Ratio of 1.13 indicates that GEHC should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.13, GEHC is doing worse than 73.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.13
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. GEHC Growth Analysis

3.1 Past

  • GEHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.00%.
  • GEHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.63% yearly.
  • The Revenue has been growing slightly by 4.85% in the past year.
  • Measured over the past years, GEHC shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%

3.2 Future

  • Based on estimates for the next years, GEHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.20% on average per year.
  • The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

7

4. GEHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.31, which indicates a correct valuation of GEHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.87% of the companies listed in the same industry.
  • GEHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 13.56, the valuation of GEHC can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 88.04% of the companies listed in the same industry.
  • GEHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 15.31
Fwd PE 13.56
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaply inside the industry as 86.96% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 86.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.23
EV/EBITDA 11.57
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • GEHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.19
PEG (5Y)N/A
EPS Next 2Y11.37%
EPS Next 3Y11.08%

3

5. GEHC Dividend Analysis

5.1 Amount

  • GEHC has a yearly dividend return of 0.18%, which is pretty low.
  • GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.21. GEHC pays more dividend than 89.67% of the companies in the same industry.
  • With a Dividend Yield of 0.18, GEHC pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

GEHC Fundamentals: All Metrics, Ratios and Statistics

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (3/12/2026, 1:37:56 PM)

70.1

-2.55 (-3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners93.29%
Inst Owner Change3.56%
Ins Owners0.3%
Ins Owner Change0.63%
Market Cap31.95B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target95.29 (35.93%)
Short Float %2.2%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)6.38%
EPS NQ rev (1m)6.22%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)2.9%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)1.1%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 15.31
Fwd PE 13.56
P/S 1.55
P/FCF 21.23
P/OCF 16.08
P/B 3.08
P/tB N/A
EV/EBITDA 11.57
EPS(TTM)4.58
EY6.53%
EPS(NY)5.17
Fwd EY7.37%
FCF(TTM)3.3
FCFY4.71%
OCF(TTM)4.36
OCFY6.22%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.19
PEG (5Y)N/A
Graham Number48.44
Profitability
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROCE 9.94%
ROIC 7.81%
ROICexc 9.32%
ROICexgc 25%
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
FCFM 7.3%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Debt/EBITDA 2.85
Cap/Depr 83.39%
Cap/Sales 2.34%
Interest Coverage 5.29
Cash Conversion 59.47%
Profit Quality 72.18%
Current Ratio 1.37
Quick Ratio 1.13
Altman-Z 1.87
F-Score4
WACC9.65%
ROIC/WACC0.81
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.